全文获取类型
收费全文 | 58785篇 |
免费 | 5435篇 |
国内免费 | 4160篇 |
专业分类
耳鼻咽喉 | 647篇 |
儿科学 | 600篇 |
妇产科学 | 564篇 |
基础医学 | 6018篇 |
口腔科学 | 875篇 |
临床医学 | 7464篇 |
内科学 | 7964篇 |
皮肤病学 | 569篇 |
神经病学 | 2784篇 |
特种医学 | 2299篇 |
外国民族医学 | 36篇 |
外科学 | 6387篇 |
综合类 | 10875篇 |
现状与发展 | 13篇 |
一般理论 | 3篇 |
预防医学 | 4191篇 |
眼科学 | 1622篇 |
药学 | 6367篇 |
53篇 | |
中国医学 | 4169篇 |
肿瘤学 | 4880篇 |
出版年
2024年 | 252篇 |
2023年 | 855篇 |
2022年 | 2314篇 |
2021年 | 2941篇 |
2020年 | 2394篇 |
2019年 | 1871篇 |
2018年 | 2013篇 |
2017年 | 1997篇 |
2016年 | 1801篇 |
2015年 | 2894篇 |
2014年 | 3620篇 |
2013年 | 3340篇 |
2012年 | 4865篇 |
2011年 | 5224篇 |
2010年 | 3625篇 |
2009年 | 2937篇 |
2008年 | 3400篇 |
2007年 | 3148篇 |
2006年 | 3069篇 |
2005年 | 2827篇 |
2004年 | 1848篇 |
2003年 | 1746篇 |
2002年 | 1441篇 |
2001年 | 1194篇 |
2000年 | 1115篇 |
1999年 | 1052篇 |
1998年 | 655篇 |
1997年 | 587篇 |
1996年 | 484篇 |
1995年 | 453篇 |
1994年 | 344篇 |
1993年 | 259篇 |
1992年 | 314篇 |
1991年 | 307篇 |
1990年 | 211篇 |
1989年 | 163篇 |
1988年 | 184篇 |
1987年 | 154篇 |
1986年 | 102篇 |
1985年 | 80篇 |
1984年 | 60篇 |
1983年 | 32篇 |
1982年 | 29篇 |
1981年 | 31篇 |
1980年 | 23篇 |
1979年 | 38篇 |
1978年 | 13篇 |
1977年 | 11篇 |
1975年 | 11篇 |
1973年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
Kevin M Kernek Matteo Brunelli Thomas M Ulbright John N Eble Guido Martignoni Shaobo Zhang Helen Michael Oscar W Cummings Liang Cheng 《Modern pathology》2004,17(11):1309-1313
The over-representation of chromosome 12p sequences is crucial for the development of invasive testicular germ cell tumors. Testicular cancer patients may have metastatic tumors of diverse histologic types, including adenocarcinoma, undifferentiated carcinoma, sarcoma, or other malignancies that lack features of germ cell tumors. We sought to investigate the possible germ cell origin of such tumors using interphase fluorescence in situ hybridization. In all, 10 metastatic malignant somatic-type tumors from patients with histories of testicular cancer, as well as one malignant somatic-type tumor from a patient with primary mediastinal germ cell tumor were studied and included: adenocarcinoma (five cases), poorly differentiated carcinoma (one), sarcoma (four), and neuroendocrine carcinoma (one). The tumors were analyzed using fluorescence in situ hybridization using 12p spectrum green and 12 centromeric spectrum orange probes in paraffin sections. The patients ranged in age from 27 to 55 years (mean, 43). Colon and lung cancers from patients without germ cell tumors were used as controls. Adequate signals were observed in all tumors. Gain of chromosome 12p was seen in six tumors. None of the control tumors showed 12p amplification. Fluorescence in situ hybridization for 12p amplification in routinely processed surgical specimens is a useful adjuvant diagnostic tool in confirming the germ cell origin of metastatic tumors having the histologic appearance of somatic-type neoplasms. 相似文献
32.
Tom C Nguyen Allen Cheng Frederick A Tibayan David Liang George T Daughters Neil B Ingels David Craig Miller 《European journal of cardio-thoracic surgery》2007,31(3):423-429
OBJECTIVE: Septal-lateral annular cinching ('SLAC') corrects both acute and chronic ischemic mitral regurgitation in animal experiments, which has led to the development of therapeutic surgical and interventional strategies incorporating this concept (e.g., Edwards GeoForm ring, Myocor Coapsys, Ample Medical PS3). Changes in left ventricular (LV) transmural cardiac and fiber-sheet strains after SLAC, however, remain unknown. METHODS: Eight normal sheep hearts had two triads of transmural radiopaque bead columns inserted adjacent to (anterobasal) and remote from (midlateral equatorial) the mitral annulus. Under acute, open chest conditions, 4D bead coordinates were obtained using videofluoroscopy before and after SLAC. Transmural systolic strains were calculated from bead displacements relative to local circumferential, longitudinal, and radial cardiac axes. Transmural cardiac strains were transformed into fiber-sheet coordinates (X(f), X(s), X(n)) oriented along the fiber (f), sheet (s), and sheet-normal (n) axes using fiber (alpha) and sheet (beta) angle measurements. Results: SLAC markedly reduced (approximately 60%) septal-lateral annular diameter at both end-diastole (ED) (2.5+/-0.3 to 1.0+/-0.3 cm, p=0.001) and end-systole (ES) (2.4+/-0.4 to 1.0+/-0.3 cm, p=0.001). In the LV wall remote from the mitral annulus, transmural systolic strains did not change. In the anterobasal region adjacent to the mitral annulus, ED wall thickness increased (p=0.01) and systolic wall thickening was less in the epicardial (0.28+/-0.12 vs 0.20+/-0.06, p=0.05) and midwall (0.36+/-0.24 vs 0.19+/-0.11, p=0.04) LV layers. This impaired wall thickening was due to decreased systolic sheet thickening (0.20+/-0.8 to 0.12+/-0.07, p=0.01) and sheet shear (-0.15+/-0.07 to -0.11+/-0.04, p=0.02) in the epicardium and sheet extension (0.21+/-0.11 to 0.10+/-0.04, p=0.03) in the midwall. Transmural systolic and remodeling strains in the lateral midwall (remote from the annulus) were unaffected. CONCLUSIONS: Although SLAC is an alluring concept to correct ischemic mitral regurgitation, these data suggest that extreme SLAC adversely effects systolic wall thickening adjacent to the mitral annulus by inhibiting systolic sheet thickening, sheet shear, and sheet extension. Such alterations in LV strains could result in unanticipated deleterious remodeling and warrant further investigation. 相似文献
33.
Shang Wen Chen Ji An Liang Shih Neng Yang Hui Ling Ko Fang Jen Lin 《Radiotherapy and oncology》2003,67(1):69-76
BACKGROUND AND PURPOSE: The potential risk of prolongation of treatment time in cervical cancer has been reported for many low-dose rate (LDR) studies, with an estimated loss of local control ranging from 0.3 to 1.6% per day of treatment prolongation. Since the treatment schedule for fractionated high-dose rate intracavitary brachytherapy (HDRICB) is not directly comparable with that for low-dose rate studies, this report aims to evaluate the adverse effect of treatment prolongation specifically for cervical cancer treated with HDRICB. MATERIAL AND METHODS: From September 1992 to December 1997, 257 patients diagnosed with uterine cervical cancer (35 Ib, 26 IIa, 122 IIb, 10 IIIa, 57 IIIb, 7 IVa), who underwent external radiotherapy combined with between two and four courses of HDRICB and a minimum of 3 years of follow-up (median 57 months), were analyzed. Treatment consisted of irradiation of the whole pelvis with 44-45 Gy consisting of 22-25 fractions by 5 weeks, with the dose boosted to 54-58 Gy (with central shielding) for patients diagnosed as FIGO stage IIb-IVa bilateral parametrial disease. HDRICB was performed using an Ir-192 remote afterloading technique at 1-week intervals. The standard prescribed dose for each course of HDRICB was 7.2 Gy to point A for three insertions (before July 1995), or 6.0 Gy to point A for four insertions (after July 1995). Total prescribed point A doses (external beam radiotherapy+HDRICB) ranged from 58 to 71.6 Gy (median, 65.6 Gy) for stage IB-IIA, while analogous dosage for larger lesions (stage IIb-IVa) ranged from 59 to 75.6 Gy (median, 65.6 Gy). Kaplan-Meier and multivariate analyses were used to test the effect of treatment time on pelvic control rate (PCR) and cause-specific survival (CSS) at 5 years. RESULTS: Median treatment time was 63 days. For all stages of disease, the 5-year CSS and PCR were significantly different comparing treatment times of less than and greater than or equal to 63 days [83% and 65% (P=0.004], 93% and 83% (P=0.02), respectively]. These associations were also significant for stage Ib/IIa [97% and 79% (P=0.01), and 100% and 87% (P=0.02), respectively), but not for stage IIb [75% and 72% (P=0.79), and 93% and 87% (P=0.83), respectively] or stage III [66% and 49% (P=0.2), and 83% and 72% (P=0.21), respectively]. Multivariate analysis identified three prognostic factors for CSS, stage (P<0.001), tumor response to external RT (P=0.001), and overall treatment time (OTT; P=0.006). Prognostic factors for pelvic failure were stage (P<0.001), tumor response to external RT (P=0.001), and OTT (P=0.03). Prolongation of treatment time resulted in a daily decrease in pelvic control rate of 0.67% overall, and 0.43% for stage Ib-IIa, 0.57% for stage IIb, and 0.73% for stage III patients. CONCLUSION: Analysis of the data from the current study demonstrates that the adverse effect of treatment prolongation was observed later in the treatment course for the high-dose rate (HDR) series compared to the LDR analog, however, treatment-time prolongation still negatively influenced the cause-specific survival and pelvic control rate for both dosage groups. 相似文献
34.
Summary Hypodermic needle shields may be used as tip protectors for several types of microsurgical instruments. These provide an inexpensive alternative to commercially available tip covers. 相似文献
35.
本文报告等容血液稀释(简称DH)治疗高血压病75例,总有效率为90.2%,48例随访2年血压下降稳定持久,血液流变学改善,总有效率为87.5%。结果表明:HD治疗高血压病可以改善血流高粘滞状态,降低血液粘度,增强血液流动性,减少血流阻力,改善微循环灌流,从而达到降低血压和改善器官血流,达到持久降压及减少器官合并症。一次HD与降压药适量配伍,疗效更显著而持久,可维持数月至2年以上。 相似文献
36.
ATP和SNP控制性降压对血流动力学的影响 总被引:1,自引:1,他引:0
对比研究三磷酸腺苷(ATP)和硝普钠(SNP)控制性降压对氯胺酮麻醉犬血流动力学的影响。选择犬14只,随机分为ATP组和SNP组,由股静脉持续输入ATP和SNP使MAP降低30% ̄40%,维持30min,分别于降压前、降压后15min、30min及停止降压后15min用Swan-Ganz漂浮导管测定血流动力学指标。结果表明,ATP、SNP降压期间SVR、LVSW显著降低,CO、PCWP、SV、RV 相似文献
37.
38.
介绍一种新型激光治疗装置.它利用超声波产生的雾化气体通道作为光学传导媒介,将激光束汇同雾化药雾通过患者的深呼吸一起传导至患者的呼吸道及肺部,进行治疗. 相似文献
39.
宣肺清热颗粒剂稳定性研究 总被引:1,自引:0,他引:1
目的:研究宣肺清热颗粒剂中橙皮甙热稳定性变化,为该颗粒剂有效期的确定、制剂生产、贮存条什提供实验参考依据。方法:采用加速实验法对橙皮甙热稳定性进行研究,用甲醇超声提取样品,HPLC进行含量测定。根据Arrhenius公式处理数据。结果:Arrhenius公式得室温下的速度常数K298=3.38×10-5/h,得出常温下该颗粒剂以橙皮甙为指标的有效期为3.6年。结论:宣肺清热颗粒剂稳定性好,初步符合中药稳定性要求。 相似文献
40.